vimarsana.com
Home
Live Updates
Cellectis Presents Clinical Data on AMELI-01 and Preclinical
Cellectis Presents Clinical Data on AMELI-01 and Preclinical
Cellectis Presents Clinical Data on AMELI-01 and Preclinical Data on Multiplex Engineering for Superior Generation of CAR T-cells at ASGCT 2023
NEW YORK, May 17, 2023 -- Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today presents clinical data... | May 17, 2023
Related Keywords
North Carolina ,
United States ,
Raleigh ,
France ,
Paris ,
France General ,
New York ,
American ,
Beatriz Aranda Orgilles ,
Mark Frattini ,
Daniel Lee ,
Arthur Stril ,
Pascalyne Wilson ,
Ashleyr Robinson ,
American Society Of Hematology ,
Cellectis The Company Euronext Growth ,
Nasdaq ,
Securities Exchange Commission ,
Clinical Sciences At Cellectis ,
Team Leader At Cellectis ,
American Society Of Gene ,
Euronext Growth ,
American Society ,
Cell Therapy ,
Clinical Data ,
Dose Regimen ,
Chief Medical Officer ,
Phasei Trial ,
Adult Patients ,
Acute Myeloid Leukemia ,
Clinical Sciences ,
Production Advances ,
Targeting Hematologic ,
Solid Tumor ,
Abstract Number ,
Team Leader ,
Multiplex Engineering ,
Superior Generation ,
Wednesday Poster ,
Board Number ,
Nasdaq Global Market ,
Private Securities Litigation Reform Act ,
Annual Report ,
Chief Business Officer ,
Lifesci Advisors ,
Cellectis Sa Stock Exchange ,
News ,
Information ,
Press Release ,
Few ,
Bay ,
023 ,
Cellectis ,
Biotechnology ,
Company ,
Sing ,
Its ,
Ioneering ,
Platform ,
O ,
Evelop ,
Fell ,
End ,
Gene ,
Oday ,
Presents ,
Linical Alcls Fr0010425595 ,